Results 21 to 30 of about 65,576 (316)
The Autoimmune Hemolytic Anemia following Septic Shock with Escherichia Coli; a Case Report
Archives of Academic Emergency Medicine, 2023 Sepsis is a severe, life-threatening illness caused when the immune system responds inappropriately to infections, causing organ deterioration and negatively affecting the systems inside the body, one of which is the coagulation system. Most hematologic
Duong Le Xuan +5 more
doaj +1 more source
European Journal of Haematology, 2022 Autoimmune hemolytic anemia (AIHA) is considered a chronic disease, with an overall good prognosis. However, recent reports indicate pre‐mature mortality. Causes of death have not been evaluated previously.
D. Hansen, S. Möller, H. Frederiksen
semanticscholar +1 more source
Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia [PDF]
, 2018 Azeredo da Silveira, Samareh +3 more
core +2 more sources
Autoimmune Hemolytic Anemia in the Pediatric Setting
Journal of Clinical Medicine, 2021 Autoimmune hemolytic anemia (AIHA) is a rare disease in children, presenting with variable severity. Most commonly, warm-reactive IgG antibodies bind erythrocytes at 37 °C and induce opsonization and phagocytosis mainly by the splenic macrophages ...
A. Voulgaridou, T. Kalfa
semanticscholar +1 more source
Autoimmune hemolytic anemia: the current state of the issue
Онкогематология, 2023 Autoimmune hemolytic anemia is a rare disease characterized by the appearance of anti-erythrocyte autoantibodies and subsequent destruction of red blood cells by cells of the immune system.
P. I. Vasilchenkova +2 more
doaj +1 more source
A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine
International Journal of Laboratory Hematology, 2021 SARS-CoV-2 mRNA vaccine made by Pfizer and BioNTech was approved by the U.S. Food and Drug Administration for use under an Emergency Use Authorization for active immunization to prevent coronavirus disease caused by severe acute respiratory syndrome ...
T. Murdych
semanticscholar +1 more source
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Frontiers in Immunology, 2020 Autoimmune hemolytic anemias mediated by cold agglutinins can be divided into cold agglutinin disease (CAD), which is a well-defined clinicopathologic entity and a clonal lymphoproliferative disorder, and secondary cold agglutinin syndrome (CAS), in ...
S. Berentsen
semanticscholar +1 more source
Infectious Complications in Autoimmune Hemolytic Anemia
Journal of Clinical Medicine, 2021 Autoimmune hemolytic anemia (AIHA) may be frequently challenged by infectious complications, mainly as a result of immunosuppressive treatments administered. Furthermore, infectious agents are known triggers of AIHA onset and relapse. Although being risk
J. Giannotta +3 more
semanticscholar +1 more source
Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine
Transfusion, 2021 Large clinical trials have demonstrated the overall safety of vaccines for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, reports have emerged of autoimmune phenomena, including vaccine‐associated myocarditis, immune ...
S. Gadi +8 more
semanticscholar +1 more source
Complement inhibitors to treat IgM-mediated autoimmune hemolysis
Haematologica, 2015 Complement activation in autoimmune hemolytic anemia may exacerbate extravascular hemolysis and may occasionally result in intravascular hemolysis. IgM autoantibodies as characteristically found in cold autoantibody autoimmune hemolytic anemia, in cold ...
Diana Wouters, Sacha Zeerleder
doaj +1 more source